[DOI] [PMC free article] [PubMed] [Google Scholar] 244.Gauthier MS, Miyoshi H, Souza SC, Cacicedo JM, Saha AK, Greenberg AS, et al
J.RaijmakersR.LemeerS.MohammedS.HeckA
Find All Groupon Sale Deals Discover IUVENTUS Medical Center's weekly Vitamin B12 shots and enjoy up to 68% off Boost mental and physical health with weekly Vitamin B12 supplementation, combatting deficiency effortlessly
J.LancasterL.SwigrisJ
Disclosures: Wen Zhang: Nothing to Disclose, Wenyue Wu: Nothing to Disclose, Ning Zhang: Nothing to Disclose, Hong Li: Nothing to Disclose, Yameng Sun: Nothing to Disclose, Xiaodong Ge: Nothing to Disclose, Hui Han: Nothing to Disclose, Shuyan Chen: Nothing to Disclose, Anjian Xu: Nothing to Disclose, Sai Santosh Babu Komakula: Nothing to Disclose, Chao Wang: Nothing to Disclose, Nithyananthan Subramaniyam: Nothing to Disclose, Qi Han: Nothing to Disclose, Xuzhen Yan: Nothing to Disclose, Aiting Yang: Nothing to Disclose, Natalia Nieto: Nothing to Disclose, Hong You: Nothing to Disclose, Wei Chen: Nothing to Disclose 2043 NOVEL BLOOD-BASED BIOMARKER MODEL FOR DIAGNOSIS OF HEPATIC FIBROSIS IN MASLD Eveline Gart Lars Verschuren 1 Anne Mak 2 Andre Boonstra 3 Joanne Verheij 4 Lise Lotte Gluud 5 Adriaan Holleboom 2 Maarten Tushuizen 6 , 1 TNO, 2 Amsterdam UMC, 3 Erasmus University Medical Center, 4 Academic Medical Center, 5 Copenhagen University - Hvidovre Hospital, 6 LUMC Background: Considering the escalating prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD) and related fibrosis, accurate non-invasive biomarkers for diagnosis and staging of fibrosis are urgently needed
5.1(0.3)%, p = 0.001] and of fasting glucose [84.7(7.2) vs
